NRG GY014

Primary Category:

Treatment Protocols

Disease Category:

Endometrial, Gynecologic, Ovarian

Status:

Temporarily Closed

A Phase II Study of Tazemetostat (EPZ-6438) (IND # 138671) in Recurrent or Persistent Endometrioid or Clear Cell Carcinoma of the Ovary, and Recurrent or Persistent Endometrioid Endometrial Adenocarcinoma

NCT#03348631